GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MAFK | hg19_v2_chr7_+_1570322_1570360 | 0.29 | 1.2e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89459813 Show fit | 34.31 |
ENST00000390256.2
|
immunoglobulin kappa variable 6-21 (non-functional) |
|
chr6_+_33043703 Show fit | 25.13 |
ENST00000418931.2
ENST00000535465.1 |
major histocompatibility complex, class II, DP beta 1 |
|
chr2_+_90060377 Show fit | 17.51 |
ENST00000436451.2
|
immunoglobulin kappa variable 6D-21 (non-functional) |
|
chr6_+_32709119 Show fit | 15.00 |
ENST00000374940.3
|
major histocompatibility complex, class II, DQ alpha 2 |
|
chr12_-_15103621 Show fit | 14.55 |
ENST00000536592.1
|
Rho GDP dissociation inhibitor (GDI) beta |
|
chr10_+_5135981 Show fit | 13.83 |
ENST00000380554.3
|
aldo-keto reductase family 1, member C3 |
|
chr3_-_121379739 Show fit | 13.62 |
ENST00000428394.2
ENST00000314583.3 |
hematopoietic cell-specific Lyn substrate 1 |
|
chr22_+_23237555 Show fit | 12.93 |
ENST00000390321.2
|
immunoglobulin lambda constant 1 (Mcg marker) |
|
chr1_+_158801095 Show fit | 12.47 |
ENST00000368141.4
|
myeloid cell nuclear differentiation antigen |
|
chr12_+_69742121 Show fit | 12.34 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
lysozyme |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 222.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.6 | 87.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
6.0 | 42.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.4 | 40.4 | GO:0031295 | T cell costimulation(GO:0031295) |
1.2 | 26.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.4 | 24.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 24.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.0 | 16.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 14.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
3.6 | 14.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 134.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 104.7 | GO:0005615 | extracellular space(GO:0005615) |
1.5 | 71.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
2.0 | 42.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 41.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 37.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.1 | 20.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 20.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 16.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.8 | 14.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 227.3 | GO:0003823 | antigen binding(GO:0003823) |
1.5 | 81.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
6.8 | 40.6 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.9 | 33.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 25.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 21.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.3 | 18.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 16.2 | GO:0051015 | actin filament binding(GO:0051015) |
1.5 | 14.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 14.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 25.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 17.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 17.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 11.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 11.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 11.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 10.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 9.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 8.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 7.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 53.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.7 | 44.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 34.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 19.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 18.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 17.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 17.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 17.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 11.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 11.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |